Shell Asset Management CO Care Dx, Inc. Transaction History

Shell Asset Management CO

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	SELL	$7.0 - $11.26 $119 - $191	-17 Reduced 0.35%	4,805 $34,000
Q2 2023 Jul 28, 2023	SELL	$7.61 - $9.46 $213 - $264	-28 Reduced 0.58%	4,822 $41,000
Q1 2023 May 15, 2023	SELL	$8.83 - $17.61 $150 - $299	-17 Reduced 0.35%	4,850 $44,000
Q4 2022 Feb 07, 2023	SELL	$10.88 - $20.05 $4,232 - $7,799	-389 Reduced 7.4%	4,867 $56,000
Q3 2022 Nov 14, 2022	SELL	$16.06 - $26.39 $11,193 - $18,393	-697 Reduced 11.71%	5,256 $89,000
Q2 2022 Aug 09, 2022	BUY	$20.49 - $39.72 $73,743 - $142,952	3,599 Added 152.89%	5,953 $128,000
Q1 2022 May 04, 2022	SELL	$28.19 - $46.6 $9,697 - $16,030	-344 Reduced 12.75%	2,354 $87,000
Q4 2021 Feb 09, 2022	BUY	$41.2 - $73.6 $3,131 - $5,593	76 Added 2.9%	2,698 $123,000
Q3 2021 Nov 04, 2021	SELL	$59.15 - $91.99 $6,506 - $10,118	-110 Reduced 4.03%	2,622 $166,000
Q2 2021 Aug 12, 2021	BUY	$63.02 - $95.11 $9,453 - $14,266	150 Added 5.81%	2,732 $250,000
Q1 2021 May 10, 2021	BUY	$57.62 - $95.6 $148,774 - $246,839	2,582 New	2,582 $176,000

218

51.1M

97.3K

43.3K

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.15B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

Stay updated on Shell Asset Management CO with notifications on news.